Panama vs Tajikistan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Panama
77.0%
in 2025
Tajikistan
79.0%
in 2025
Panama rank
124th
Tajikistan rank
121st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Panama
- Tajikistan
How they compare
Tajikistan currently reports 79.0% against 77.0% in Panama, a difference of 2.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Tajikistan ahead.
Panama ranks 124th and Tajikistan ranks 121st of 194 countries.
Panama has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Panama | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 84.2% | 0.0% | 84.2% | Panama |
| 2020s | 80.7% | 31.3% | 49.3% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Panama or Tajikistan?
- Tajikistan, at 79.0% against 77.0% in Panama as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Panama and Tajikistan?
- 2.0%, with Tajikistan ahead.
- How many years of comparable data are there for Panama and Tajikistan?
- 18 years are reported by both, from 2008 to 2025.
- How do Panama and Tajikistan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Panama ranks 124th and Tajikistan ranks 121st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.